Mersana Therapeutics

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.

Caedo Oncology

This company develops monoclonal antibody therapeutics that induce programmed cell death in cancer cells for healthcare providers and patients.

CrossBridge Bio

This company develops dual-payload antibody-drug conjugates to treat solid tumors for healthcare providers and pharmaceutical partners.

Pheon Therapeutics

The company develops antibody-drug conjugates to treat solid tumours for the healthcare and pharmaceutical sectors.

CytomX

This biopharmaceutical company develops conditionally activated antibody therapeutics for oncology patients and healthcare providers.

Ona Therapeutics

This company develops antibody-drug conjugates to treat patients with advanced and metastatic cancers which have become resistant to existing therapies.

Curis

This biotechnology company develops drug candidates for the treatment of various cancers and hematologic malignancies for healthcare providers and patients.

Clinical stage immunotherapy company

This company develops next-generation antibody-drug conjugates to treat patients with solid tumor malignancies.